3-weekly or weekly cisplatin concurrently with radiotherapy for patients with squamous cell carcinoma of the head and neck – a multicentre, retrospective analysis

3-weekly or weekly cisplatin concurrently with radiotherapy for patients with squamous cell carcinoma of the head and neck – a multicentre, retrospective analysis

Abstract Background Concurrent chemoradiotherapy with cisplatin is standard for patients (pts) with loco-regionally advanced squamous cell carcinoma of the head and neck (LA-SCCHN) and for patients with resected SCCHN with high-risk features. The standard regimen includes 3-weekly cisplatin, but wee...

Full description

Bibliographic Details
Main Authors: Seth Helfenstein, Oliver Riesterer, Urs R. Meier, Alexandros Papachristofilou, Benjamin Kasenda, Miklos Pless, Sacha I. Rothschild
Format: Article
Language:English
Published: BMC 2019-02-01
Series:Radiation Oncology
Subjects:
Head and neck squamous carcinoma
Chemo-radiotherapy
Treatment
Cisplatin
Dose
Online Access:http://link.springer.com/article/10.1186/s13014-019-1235-y

Internet

http://link.springer.com/article/10.1186/s13014-019-1235-y

Similar Items